Start Date
June 30, 2010
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Liposome Entrapped Docetaxel (LE-DT)
110 mg/m2 IV (in vein) on day 1 of each 21 day cycle, 6 cycles or until disease progression or unacceptable toxicity
Georgetown University Medical center, Washington D.C.
Providence Portland Medical center, Portland
Lead Sponsor
INSYS Therapeutics Inc
INDUSTRY